Search

Purpose: This study was conducted to determine the validity and reliability of the Turkish version of the Resilience Scale for Young Children., Method: This study used a methodological and descriptive design. The study was conducted with 210 parents of children aged 2-6 years at a Family Health Centre in Sakarya from June 2023 to January 2024. Data was collected by face-to-face interviews via a Descriptive Information Form and the Chinese Resilience Scale for Young Children. Translation processes, expert opinions, and content validity were meticulously addressed. Data analysis was utilized by IBM SPSS Statistics and AMOS 24., Result: The mean age of parents was 35.85 ± 6.52 years, and 82.9% of the parents were mothers (n = 174). The item-content validity index (I-CVI) ranged between 0.81 and 0.94, indicating a high level of agreement between the experts. The Cronbach's alpha value for the scale was 0.791. In the exploratory factor analysis, it was determined that the distribution of the items according to the sub-dimensions was consistent with the original scale. Confirmatory factor analysis results are as follows: chi-square/df = 2.395, RMSEA = 0.082, GFI = 0.842, CFI = 0.853, IFI = 0.856, RFI = 0.726, NFI = 0.776 and TLI = 0.820., Conclusion: This study revealed that the Turkish scale with four sub-dimensions and 16 items is a valid and reliable tool., Practice Implications: It is recommended to use the Turkish version of the Resilience Scale for Young Children to assess resilience in children aged 2-6 years., Competing Interests: Declaration of competing interest The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (Copyright © 2024 Elsevier Inc. All rights reserved.)

Background: Nonpharmacological interventions are needed to reduce pain during vaccine administration in infants., Purpose: To determine the effect of the Buzzy device, which is a combination of cold and vibration, on pain during measles-mumps-rubella (MMR) vaccine administration in 12-month-old infants., Methods: A prospective randomized controlled experimental research design was used., Results: A total of 60 infants were included in the study. During and after vaccine injection, pain scores of infants who had the Buzzy device were significantly lower than those of infants in the control group ( P = .001)., Conclusions: Buzzy application may be an effective method in reducing pain during MMR vaccine administration. Use of the device is recommended for infants receiving vaccinations., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)